Quality assurance of drug information: A prerequisite for the quality assurance of any drug therapy

Immo Fiebrig, Marion Schulte Van Werde, Karl Heinz Munter

Research output: Contribution to journalArticle

Abstract

The quality of drug information has a substantial influence on the success of medical treatment. Whilst quality assurance of pharmaceutical products is thoroughly regulated, there are still substantial loopholes in the process of generating, processing and presenting the required drug information. Practical methods of quality assurance in the editing process of scientific databases are shown, alongside current quality-related initiatives and standards in the area of healthcare information. The aim is to reduce the risks and side effects caused by poor quality drug information.

Translated title of the contributionQuality assurance of drug information: A prerequisite for the quality assurance of any drug therapy
Original languageGerman
Pages (from-to)377-381
Number of pages5
JournalKrankenhauspharmazie
Volume27
Issue number9
Publication statusPublished - Sep 2006
Externally publishedYes

Fingerprint

Drug Therapy
Pharmaceutical Preparations
Databases
Delivery of Health Care
Therapeutics

Keywords

  • Drug database
  • Drug information system
  • Editing process
  • Quality assurance
  • Quality management

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Qualitätssicherung der arzneimittel-information : Voraussetzung für qualitätsgesicherte arzneimitteltherapie. / Fiebrig, Immo; Van Werde, Marion Schulte; Munter, Karl Heinz.

In: Krankenhauspharmazie, Vol. 27, No. 9, 09.2006, p. 377-381.

Research output: Contribution to journalArticle

Fiebrig, Immo ; Van Werde, Marion Schulte ; Munter, Karl Heinz. / Qualitätssicherung der arzneimittel-information : Voraussetzung für qualitätsgesicherte arzneimitteltherapie. In: Krankenhauspharmazie. 2006 ; Vol. 27, No. 9. pp. 377-381.
@article{cd446559b7bd4a698260bf02ec7b8563,
title = "Qualit{\"a}tssicherung der arzneimittel-information: Voraussetzung f{\"u}r qualit{\"a}tsgesicherte arzneimitteltherapie",
abstract = "The quality of drug information has a substantial influence on the success of medical treatment. Whilst quality assurance of pharmaceutical products is thoroughly regulated, there are still substantial loopholes in the process of generating, processing and presenting the required drug information. Practical methods of quality assurance in the editing process of scientific databases are shown, alongside current quality-related initiatives and standards in the area of healthcare information. The aim is to reduce the risks and side effects caused by poor quality drug information.",
keywords = "Drug database, Drug information system, Editing process, Quality assurance, Quality management",
author = "Immo Fiebrig and {Van Werde}, {Marion Schulte} and Munter, {Karl Heinz}",
year = "2006",
month = "9",
language = "German",
volume = "27",
pages = "377--381",
journal = "Krankenhauspharmazie",
issn = "0173-7597",
publisher = "Deutscher Apotheker Verlag",
number = "9",

}

TY - JOUR

T1 - Qualitätssicherung der arzneimittel-information

T2 - Voraussetzung für qualitätsgesicherte arzneimitteltherapie

AU - Fiebrig, Immo

AU - Van Werde, Marion Schulte

AU - Munter, Karl Heinz

PY - 2006/9

Y1 - 2006/9

N2 - The quality of drug information has a substantial influence on the success of medical treatment. Whilst quality assurance of pharmaceutical products is thoroughly regulated, there are still substantial loopholes in the process of generating, processing and presenting the required drug information. Practical methods of quality assurance in the editing process of scientific databases are shown, alongside current quality-related initiatives and standards in the area of healthcare information. The aim is to reduce the risks and side effects caused by poor quality drug information.

AB - The quality of drug information has a substantial influence on the success of medical treatment. Whilst quality assurance of pharmaceutical products is thoroughly regulated, there are still substantial loopholes in the process of generating, processing and presenting the required drug information. Practical methods of quality assurance in the editing process of scientific databases are shown, alongside current quality-related initiatives and standards in the area of healthcare information. The aim is to reduce the risks and side effects caused by poor quality drug information.

KW - Drug database

KW - Drug information system

KW - Editing process

KW - Quality assurance

KW - Quality management

UR - http://www.scopus.com/inward/record.url?scp=33749404800&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 377

EP - 381

JO - Krankenhauspharmazie

JF - Krankenhauspharmazie

SN - 0173-7597

IS - 9

ER -